OCGN Ocugen, Inc. Stock Quote

OCGN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.27	Insider Own	0.50%	Shs Outstand	195.57M	Perf Week	10.91%
Market Cap	1.62B	Forward P/E	31.98	EPS next Y	0.25	Insider Trans	-53.86%	Shs Float	193.90M	Perf Month	10.75%
Income	-47.30M	PEG	-	EPS next Q	-0.04	Inst Own	28.80%	Short Float	26.34%	Perf Quarter	20.70%
Sales	0.04M	P/S	38066.60	EPS this Y	79.00%	Inst Trans	123.75%	Short Ratio	2.85	Perf Half Y	-11.10%
Book/sh	0.60	P/B	13.22	EPS next Y	189.30%	ROA	-83.70%	Target Price	7.90	Perf Year	2218.71%
Cash/sh	0.57	P/C	14.03	EPS next 5Y	-	ROE	-95.10%	52W Range	0.25 - 18.77	Perf YTD	333.33%
Dividend	-	P/FCF	-	EPS past 5Y	70.80%	ROI	-	52W High	-57.75%	Beta	4.52
Dividend %	-	Quick Ratio	25.10	Sales past 5Y	-	Gross Margin	-	52W Low	3070.73%	ATR	0.54
Employees	15	Current Ratio	25.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	55.63	Volatility	10.26% 6.50%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	31.40%	Profit Margin	-	Rel Volume	0.81	Prev Close	7.54
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Aug 06 BMO	Payout	-	Avg Volume	17.91M	Price	7.93
Recom	2.60	SMA20	6.18%	SMA50	8.45%	SMA200	17.43%	Volume	14,562,612	Change	5.17%

Jul-26-21

Initiated

Noble Capital Markets

Outperform

Jun-11-21

Downgrade

ROTH Capital

Buy → Neutral

$10 → $6

May-07-21

Downgrade

Cantor Fitzgerald

Overweight → Neutral

Feb-09-21

Downgrade

Chardan Capital Markets

Buy → Neutral

$0.70 → $13

Feb-04-21

Upgrade

H.C. Wainwright

Neutral → Buy

$4.50

Sep-17-21 04:52PM	Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +5.17%
11:17AM	Why COVID Vaccine Stocks BioNTech, Moderna, and Novavax Are Sliding While Ocugen Is Rising Motley Fool
Sep-15-21 12:33PM	10 Cheap Small-Cap Stocks to Buy Insider Monkey
08:34AM	Do Options Traders Know Something About Ocugen (OCGN) Stock We Don't? Zacks
Sep-13-21 02:10PM	Here's Why Ocugen Is Skyrocketing Today Motley Fool +15.80%
Sep-10-21 10:50PM	OCUGEN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ocugen, Inc. - OCGN Business Wire
Sep-07-21 05:22PM	Ocugen, Inc. to Present at Upcoming Citi and H.C. Wainwright Investment Conferences GlobeNewswire
Sep-02-21 02:25PM	7 Short Squeeze Stocks to Sell Before Reddit Traders Cash Out InvestorPlace
Aug-30-21 11:46AM	Top Small-Cap Stocks for September 2021 Investopedia
Aug-27-21 02:55PM	The Odds Are Firmly Against Ocugen Stock Now InvestorPlace
Aug-25-21 09:12AM	2 Popular Robinhood Stocks I Wouldn't Buy With Free Money Motley Fool
Aug-20-21 04:34PM	Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +6.10%
Aug-19-21 09:49AM	11 Biotech Stocks Popular On Reddit Insider Monkey
Aug-17-21 12:25PM	LAWSUITS FILED AGAINST OCGN, DKNG and PLL - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:48AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
11:00AM	Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. (OCGN) Investors With Losses Exceeding $100K of Class Action ACCESSWIRE
09:42AM	OCGN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 17, 2021 in the Class Action Filed on Behalf of Ocugen, Inc. Limited Shareholders Newsfile
09:19AM	OCGN FINAL DEADLINE TODAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 17 Deadline in Securities Class Action OCGN GlobeNewswire
08:00AM	Ocugen, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
Aug-16-21 06:02PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN Newsfile
04:25PM	Final Deadline Tuesday: Rosen, Leading Investor Counsel, Encourages Ocugen, Inc. Investors with Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action - OCGN Newsfile
01:20PM	CLASS ACTION UPDATE for OCGN, HMPT and ARDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:44AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
11:40AM	DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:30AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, OCGN and OTLY ACCESSWIRE
10:00AM	OCGN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm Newsfile
Aug-15-21 12:38PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN Newsfile
11:50AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, AHCO and ATVI ACCESSWIRE
10:10AM	FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OCGN Newsfile
Aug-13-21 08:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ocugen, Inc. and Encourages Investors to Contact the Firm Business Wire -6.90%
07:18PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN Newsfile
05:50PM	FINAL DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors With Losses To Secure Counsel Before Important Deadline In Securities Class Action - OCGN PR Newswire
04:58PM	LAWSUITS FILED AGAINST OCGN, DKNG and BZ - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
04:38PM	Ocugen Now Relies Solely on a Continued Covid-19 Crisis InvestorPlace
04:10PM	DEADLINE NEXT TUESDAY: Shareholders with Substantial Losses Have Opportunity to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN PR Newswire
01:00PM	CLASS ACTION UPDATE for OCGN, REKR and BLCT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:45PM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN) Business Wire
11:45AM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN) Business Wire
11:45AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, BLCT and OTLY ACCESSWIRE
11:08AM	TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
11:00AM	OCGN Looming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: August 17, 2021 ACCESSWIRE
Aug-12-21 05:35PM	SHAREHOLDER ALERT: OCGN BZ PLL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:59PM	Moore Kuehn, PLLC Encourages Investors of OCGN to Contact Law Firm Newsfile
11:20AM	CLASS ACTION UPDATE for OCGN, RKT and BZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:03AM	TUESDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
10:00AM	OCGN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm Business Wire
09:36AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN Newsfile
08:00AM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN) GlobeNewswire
Aug-11-21 08:25PM	SHAREHOLDER ALERT: OCGN DKNG OTLY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE -7.40%
08:17PM	Ocugen, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
08:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, RenovaCare, and AdaptHealth and Encourages Investors to Contact the Firm GlobeNewswire
07:47PM	ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action OCGN GlobeNewswire
12:10PM	Lawsuits Filed Against OCGN, CRMD and ARDX - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:00AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, CRMD and AHCO ACCESSWIRE
11:00AM	OCGN, TEDU & HMPT Looming Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC ACCESSWIRE
10:10AM	TUESDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
08:38AM	Implied Volatility Surging for Ocugen (OCGN) Stock Options Zacks
Aug-10-21 02:14PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN Newsfile
12:45PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
12:00PM	LAWSUITS FILED AGAINST JRVR, OCGN and LOTZ - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:00AM	OCGN Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: August 17, 2021 ACCESSWIRE
11:00AM	DEADLINE ALERT for OCGN, TEDU, ATHA, REKR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:45AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, CRMD and AHCO ACCESSWIRE
09:43AM	7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
Aug-09-21 01:00PM	CLASS ACTION UPDATE for RLX, OCGN and HMPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:55AM	INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
11:45AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, HMPT and ARDX ACCESSWIRE
11:30AM	DEADLINE ALERT for OCGN, HMPT, TEDU, and ATHA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:00AM	OCGN, TEDU & HMPT Upcoming Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC ACCESSWIRE
10:15AM	SHAREHOLDER ALERT: OCGN YMM DIDI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:50AM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
Aug-06-21 08:01PM	Ocugen, Inc. (OCGN) Q2 2021 Earnings Call Transcript Motley Fool
04:01PM	Why Ocugen Is Rallying Today Motley Fool
02:00PM	LAWSUITS FILED AGAINST OCGN, BLCT and ZY - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
12:32PM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
11:52AM	Ocugen sees 77.8% efficacy in phase 3 trial for COVID-19 vaccine Yahoo Finance Video
11:15AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, QFIN and ATVI ACCESSWIRE
10:37AM	OCGN BREAKING NOTICE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action OCGN GlobeNewswire
08:32AM	Ocugen's (OCGN) Q2 Earnings Miss Estimates, Stock Down Zacks
07:32AM	Ocugen Provides Business Update and Second Quarter 2021 Financial Results GlobeNewswire
Aug-05-21 02:10PM	CLASS ACTION UPDATE for OCGN, LOTZ and BLCT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE +10.31%
11:06AM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
06:28AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN Newsfile
05:40AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, HMPT and YMM ACCESSWIRE
Aug-04-21 08:40PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, HMPT and DKNG ACCESSWIRE
08:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, RenovaCare, and AdaptHealth and Encourages Investors to Contact the Firm GlobeNewswire
02:00PM	CLASS ACTION UPDATE for OCGN, DKNG and LOTZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:20PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
01:00PM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN) GlobeNewswire
12:50PM	SHAREHOLDER ALERT: OCGN DKNG CXO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:00PM	OCGN LOSS ALERT: ROSEN, A TOP RANKED INVESTOR RIGHTS LAW FIRM, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - OCGN ACCESSWIRE
11:30AM	LAWSUITS FILED AGAINST OCGN, ATHA and CRMD - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:03AM	INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm Newsfile
11:00AM	OCGN ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating Ocugen, Inc. (NASDAQ:OCGN) for Potential Securities Violations and Breach of Fiduciary Duty ACCESSWIRE
05:34AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN Newsfile
Aug-03-21 10:25PM	SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocugen, Inc. of Class Action Lawsuit and Upcoming Deadline - OCGN PR Newswire
01:30PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of JRVR, OCGN and OTLY ACCESSWIRE
01:30PM	OCGN ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating Ocugen, Inc. (NASDAQ:OCGN) for Potential Securities Violations and Breach of Fiduciary Duty ACCESSWIRE
12:00PM	DEADLINE ALERT for OCGN, TEDU, ATHA, REKR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:33AM	Ocugen (OCGN) to Report Q2 Earnings: What's in the Cards? Zacks

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Musunuri Shankar	Chief Executive Officer	Sep 15	Option Exercise	0.33	125,000	41,250	531,000	Sep 17 04:01 PM
Musunuri Shankar	Chief Executive Officer	Sep 15	Sale	7.52	125,000	940,000	406,000	Sep 17 04:01 PM
Subramanian Sanjay	Chief Financial Officer	Aug 16	Option Exercise	0.34	30,000	10,200	75,591	Aug 18 04:01 PM
Subramanian Sanjay	Chief Financial Officer	Aug 16	Sale	7.22	30,000	216,600	45,591	Aug 18 04:01 PM
Kompella Uday	Director	Jul 30	Option Exercise	1.83	10,000	18,300	560,674	Jul 30 05:28 PM
Kompella Uday	Director	Jul 30	Sale	6.81	10,000	68,072	550,674	Jul 30 05:28 PM
Kumar Ramesh	Director	Jul 19	Option Exercise	0.51	7,500	3,825	7,500	Jul 21 04:04 PM
Kumar Ramesh	Director	Jul 19	Sale	6.40	7,500	48,000	0	Jul 21 04:04 PM
Subramanian Sanjay	Chief Financial Officer	Jul 15	Option Exercise	0.34	31,086	10,569	76,677	Jul 16 04:01 PM
Subramanian Sanjay	Chief Financial Officer	Jul 15	Sale	6.70	31,086	208,276	45,591	Jul 16 04:01 PM
Kompella Uday	Director	Jun 25	Option Exercise	1.83	10,000	18,300	560,674	Jun 25 04:17 PM
Kompella Uday	Director	Jun 25	Sale	8.13	10,000	81,345	550,674	Jun 25 04:17 PM
Subramanian Sanjay	Chief Financial Officer	Jun 15	Option Exercise	0.34	31,000	10,540	76,591	Jun 17 05:25 PM
Subramanian Sanjay	Chief Financial Officer	Jun 15	Sale	7.00	31,000	217,000	45,591	Jun 17 05:25 PM
Potti Manish	Director	Jun 15	Sale	8.86	68,185	604,119	91,124	Jun 17 05:23 PM
Musunuri Shankar	Chief Executive Officer	Jun 08	Option Exercise	0.33	22,800	7,524	428,800	Jun 09 07:22 PM
Musunuri Shankar	Chief Executive Officer	Jun 08	Sale	10.98	22,800	250,344	406,000	Jun 09 07:22 PM
Musunuri Shankar	Chief Executive Officer	Jun 07	Option Exercise	0.33	7,758	2,560	413,758	Jun 09 07:22 PM
Castillo Kirsten	Director	Jun 07	Sale	10.00	10,000	100,000	65,000	Jun 09 07:21 PM
Musunuri Shankar	Chief Executive Officer	Jun 07	Sale	10.94	7,758	84,873	406,000	Jun 09 07:22 PM
Kompella Uday	Director	May 28	Option Exercise	1.88	7,191	13,519	557,865	Jun 01 06:10 AM
Kompella Uday	Director	May 28	Sale	8.82	7,191	63,417	550,674	Jun 01 06:10 AM
Fernandes Prabhavathi	Director	May 25	Option Exercise	0.93	33,500	31,080	19,500	May 27 04:07 PM
Fernandes Prabhavathi	Director	May 25	Sale	8.20	33,500	274,755	0	May 27 04:07 PM
Subramanian Sanjay	Chief Financial Officer	May 14	Option Exercise	0.34	31,000	10,540	76,591	May 14 04:58 PM
Subramanian Sanjay	Chief Financial Officer	May 14	Sale	8.18	31,000	253,673	45,591	May 14 04:58 PM
Tammara Vijay	Senior Vice President	May 04	Option Exercise	0.81	15,711	12,755	6,500	May 05 08:15 PM
Tammara Vijay	Senior Vice President	May 04	Sale	13.68	15,711	214,954	0	May 05 08:15 PM
Musunuri Shankar	Chief Executive Officer	May 03	Option Exercise	0.51	195,809	99,863	601,809	May 03 09:00 PM
Tammara Vijay	Senior Vice President	May 03	Option Exercise	0.46	4,317	1,986	4,317	May 03 08:53 PM
Potti Manish	Director	May 03	Sale	15.02	60,000	901,200	63,429	May 05 08:13 PM
Potti Manish	Director	May 03	Sale	15.01	28,000	420,280	0	May 05 08:13 PM
Tammara Vijay	Senior Vice President	May 03	Sale	16.00	4,317	69,072	0	May 03 08:53 PM
Kompella Uday	Director	May 03	Sale	15.01	50,000	750,500	550,674	May 03 09:05 PM
Musunuri Shankar	Chief Executive Officer	May 03	Sale	14.24	195,809	2,788,320	406,000	May 03 09:00 PM
Kompella Uday	Director	Apr 30	Option Exercise	0.51	20,000	10,200	620,674	May 03 09:05 PM
Kompella Uday	Director	Apr 30	Sale	11.56	20,000	231,200	600,674	May 03 09:05 PM
Tammara Vijay	Senior Vice President	Apr 29	Option Exercise	0.75	29,991	22,442	12,880	May 03 08:53 PM
Subramanian Sanjay	Chief Financial Officer	Apr 29	Option Exercise	2.19	7,990	17,498	53,581	May 03 09:06 PM
Subramanian Sanjay	Chief Financial Officer	Apr 29	Sale	10.98	7,990	87,730	45,591	May 03 09:06 PM
Tammara Vijay	Senior Vice President	Apr 29	Sale	10.97	29,991	328,881	0	May 03 08:53 PM
Kompella Uday	Director	Apr 26	Sale	11.70	350,000	4,095,000	600,674	Apr 28 06:52 PM
Kumar Ramesh	Director	Apr 19	Option Exercise	0.51	7,500	3,825	7,500	Apr 21 04:16 PM
Kumar Ramesh	Director	Apr 19	Sale	5.33	7,500	39,975	0	Apr 21 04:16 PM
Potti Manish	Director	Mar 05	Option Exercise	0.84	28,000	23,520	28,000	Mar 08 08:38 PM
Subramanian Sanjay	Chief Financial Officer	Jan 29	Option Exercise	0.51	35,591	18,151	45,591	Feb 01 05:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience